AD/PDâ„¢ 2026 is a leading international conference dedicated to neurodegenerative diseases, convening top medical and scientific experts to present novel findings that advance understanding of disease ...
GOTHENBURG, SE / ACCESS Newswire / February 18, 2026 / IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A)(STO:IRLAB-A)(FRA:6IRA ...
Session: Oral Poster Presentation – Guided Poster TourSession Date: Saturday, May 10, 2025Session Time: 8:00-9:00 a.m. EST About GT-02287Gain Therapeutics’ lead drug candidate, GT-02287, is in ...
NEW HAVEN, Conn., March 27, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today ...
You would be hard pressed to find someone whose life hasn't been affected in some way by Parkinson's disease, the second most common neurodegenerative disorder after Alzheimer's.
Fox Foundation for Parkinson's Research (MJFF) announces the arrival of the national event series "Parkinson's IQ + You" to Southern Nevada. Since 2019, Parkinson's IQ + You events have traveled to 23 ...
Researchers at the University of Missouri may have uncovered a clue explaining why young adults with autism are roughly six times more likely to develop Parkinson's disease later in life. In a recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results